ML24059A128: Difference between revisions
StriderTol (talk | contribs) (StriderTol Bot insert) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 15: | Line 15: | ||
=Text= | =Text= | ||
{{#Wiki_filter:UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 | {{#Wiki_filter:UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 February 28, 2024 Mr. Miroslav Lazarevich Federal Advisory Committee Desk Library of Congress Anglo-American Acquisition Division Government Documents Section, Room LM-B42 101 Independence Avenue, SE Washington, DC 20540-4274 | ||
February 28, 2024 | |||
Mr. Miroslav Lazarevich Federal Advisory Committee Desk Library of Congress Anglo-American Acquisition Division Government Documents Section, Room LM-B42 101 Independence Avenue, SE Washington, DC | |||
==Dear Mr. Lazarevich:== | ==Dear Mr. Lazarevich:== | ||
In accordance with Section 9 of the Federal Advisory Committee Act, the Nuclear Regulatory Commission hereby files the enclosed renewed Charter for the Advisory Committee on the Medical Uses of Isotopes. The Charter was last filed in February 2022 and is being renewed at this time. | In accordance with Section 9 of the Federal Advisory Committee Act, the Nuclear Regulatory Commission hereby files the enclosed renewed Charter for the Advisory Committee on the Medical Uses of Isotopes. The Charter was last filed in February 2022 and is being renewed at this time. | ||
Sincerely, Russell E. Chazell Advisory Committee Management Officer | |||
Sincerely, | |||
Russell E. Chazell | |||
==Attachment:== | ==Attachment:== | ||
As Stated | |||
As Stated | |||
UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES | UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES | ||
: 1. | : 1. Committees Official Designation (Title): | ||
Advisory Committee on the Medical Uses of Isotopes (the Committee or ACMUI) | Advisory Committee on the Medical Uses of Isotopes (the Committee or ACMUI) | ||
: 2. Authority: | : 2. Authority: | ||
The Committee is established pursuant to 42 United States Code § 2201(a) as an NRC discretionary committee in accordance with the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. § 1001 et. seq. | The Committee is established pursuant to 42 United States Code § 2201(a) as an NRC discretionary committee in accordance with the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. § 1001 et. seq. | ||
: 3. | : 3. Objectives and Scope of Activities: | ||
The Committee provides advice, as requested by the Director, Division of Materials Safety, Security, State, and Tribal Programs (MSST), Office of Nuclear Material Safety and Safeguards (NMSS), on policy and technical issues that arise in the regulation of the medical uses of radioactive material for diagnosis and therapy. | The Committee provides advice, as requested by the Director, Division of Materials Safety, Security, State, and Tribal Programs (MSST), Office of Nuclear Material Safety and Safeguards (NMSS), on policy and technical issues that arise in the regulation of the medical uses of radioactive material for diagnosis and therapy. | ||
: 4. | : 4. Description of Duties: | ||
The Committee comments on changes to relevant NRC regulations and guidance; evaluates certain non-routine uses of radioactive material; provides technical assistance in licensing, inspection, and enforcement cases; and brings key issues to the attention of the agency for appropriate action. The Committee members may also serve as medical consultants to the Director, MSST, as requested. | |||
The Committee comments on changes to relevant NRC regulations and guidance; evaluates certain non-routine uses of radioactive material ; provides technical assistance in licensing, inspection, and enforcement cases; and brings key issues to the attention of the agency for appropriate action. The Committee members may also serve as medical consultants to the Director, MSST, as requested. | : 5. Official to Whom this Committee Reports: | ||
: 5. | |||
Director, Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission Washington, DC 20555 | Director, Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission Washington, DC 20555 | ||
: 6. | : 6. Agency Responsible for Providing Necessary Support to this Committee: | ||
U.S. Nuclear Regulatory Commission. | U.S. Nuclear Regulatory Commission. | ||
: 7. | : 7. Estimated Annual Operating Costs and Staff Years: | ||
As of the date of this charter, estimated annual operating costs for the full committee total | |||
As of the date of this charter, estimated annual operating costs for the full committee total | $308,000. These costs include 1.55 FTE (1.06 FTE for NRC support staff salary and benefits and 0.49 FTE for ACMUI member compensation) and travel reimbursements for NRC staff, ACMUI members, and consultants. | ||
: 8. Designated Federal Officer: | |||
: 8. | A full-time NRC employee from the NRCs Division of Materials Safety, Security, State, and Tribal Programs will serve as the Designated Federal Officer (DFO). The DFO will approve or | ||
A full-time NRC employee from the NRCs | |||
call all of the committee and subcommittee meetings, prepare and approve all meeting agendas, attend all committee and subcommittee meetings, adjourn any meeting when the DFO determines adjournment to be in the public interest, and chair meetings when directed to do so by the Director, MSST. | |||
: 9. Estimated Number of Meetings per Year: | |||
Approximately six meetings per year, four of which are web conferences, with video and telephone capabilities. | Approximately six meetings per year, four of which are web conferences, with video and telephone capabilities. | ||
: 10. Duration: | : 10. Duration: | ||
Continuing Committee. | Continuing Committee. | ||
: 11. | : 11. Termination: | ||
Unless renewed by appropriate action, the Committee will terminate two-years from the date this charter is filed. | Unless renewed by appropriate action, the Committee will terminate two-years from the date this charter is filed. | ||
: 12. Membership and Designation: | |||
12.Membership and Designation: | With the exception of one regular Government employee representing the U.S. Food and Drug Administration, members are appointed by the Director, NMSS as Special Government Employees. The Committee consists of 13 members, including health care professionals in diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration, and patient care advocacy, and an Agreement State representative. | ||
: 13. Subcommittees: | |||
With the exception of one regular Government employee representing the U.S. Food and Drug Administration, members are appointed by the Director, NMSS as Special Government Employees. The Committee consists of 13 members, including health care professionals in diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration, and patient care advocacy, | |||
13.Subcommittees: | |||
The Committee does not have standing subcommittees. The full Committee may create ad hoc subcommittees that report to the full Committee. | The Committee does not have standing subcommittees. The full Committee may create ad hoc subcommittees that report to the full Committee. | ||
: 14. Recordkeeping: | |||
14.Recordkeeping: | |||
The Committee records will be handled in accordance with General Records Schedule 6.2 and approved NRC records disposition schedules. These records shall be available for public inspection and copying, subject to the Freedom of Information Act, 5 U.S.C. 552. | The Committee records will be handled in accordance with General Records Schedule 6.2 and approved NRC records disposition schedules. These records shall be available for public inspection and copying, subject to the Freedom of Information Act, 5 U.S.C. 552. | ||
: 15. | : 15. Filing date: | ||
February 28, 2024 Russell E. Chazell Federal Advisory Committee Management Officer Office of the Secretary}} | |||
February 28, 2024 | |||
Russell E. Chazell Federal Advisory Committee Management Officer Office of the Secretary}} | |||
Latest revision as of 19:56, 24 November 2024
| ML24059A128 | |
| Person / Time | |
|---|---|
| Issue date: | 02/28/2024 |
| From: | Russell Chazell NRC/SECY/RAS |
| To: | Lazarevich M US Library of Congress |
| References | |
| Download: ML24059A128 (1) | |
Text
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 February 28, 2024 Mr. Miroslav Lazarevich Federal Advisory Committee Desk Library of Congress Anglo-American Acquisition Division Government Documents Section, Room LM-B42 101 Independence Avenue, SE Washington, DC 20540-4274
Dear Mr. Lazarevich:
In accordance with Section 9 of the Federal Advisory Committee Act, the Nuclear Regulatory Commission hereby files the enclosed renewed Charter for the Advisory Committee on the Medical Uses of Isotopes. The Charter was last filed in February 2022 and is being renewed at this time.
Sincerely, Russell E. Chazell Advisory Committee Management Officer
Attachment:
As Stated
UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES
- 1. Committees Official Designation (Title):
Advisory Committee on the Medical Uses of Isotopes (the Committee or ACMUI)
- 2. Authority:
The Committee is established pursuant to 42 United States Code § 2201(a) as an NRC discretionary committee in accordance with the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. § 1001 et. seq.
- 3. Objectives and Scope of Activities:
The Committee provides advice, as requested by the Director, Division of Materials Safety, Security, State, and Tribal Programs (MSST), Office of Nuclear Material Safety and Safeguards (NMSS), on policy and technical issues that arise in the regulation of the medical uses of radioactive material for diagnosis and therapy.
- 4. Description of Duties:
The Committee comments on changes to relevant NRC regulations and guidance; evaluates certain non-routine uses of radioactive material; provides technical assistance in licensing, inspection, and enforcement cases; and brings key issues to the attention of the agency for appropriate action. The Committee members may also serve as medical consultants to the Director, MSST, as requested.
- 5. Official to Whom this Committee Reports:
Director, Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission Washington, DC 20555
- 6. Agency Responsible for Providing Necessary Support to this Committee:
U.S. Nuclear Regulatory Commission.
- 7. Estimated Annual Operating Costs and Staff Years:
As of the date of this charter, estimated annual operating costs for the full committee total
$308,000. These costs include 1.55 FTE (1.06 FTE for NRC support staff salary and benefits and 0.49 FTE for ACMUI member compensation) and travel reimbursements for NRC staff, ACMUI members, and consultants.
- 8. Designated Federal Officer:
A full-time NRC employee from the NRCs Division of Materials Safety, Security, State, and Tribal Programs will serve as the Designated Federal Officer (DFO). The DFO will approve or
call all of the committee and subcommittee meetings, prepare and approve all meeting agendas, attend all committee and subcommittee meetings, adjourn any meeting when the DFO determines adjournment to be in the public interest, and chair meetings when directed to do so by the Director, MSST.
- 9. Estimated Number of Meetings per Year:
Approximately six meetings per year, four of which are web conferences, with video and telephone capabilities.
- 10. Duration:
Continuing Committee.
- 11. Termination:
Unless renewed by appropriate action, the Committee will terminate two-years from the date this charter is filed.
- 12. Membership and Designation:
With the exception of one regular Government employee representing the U.S. Food and Drug Administration, members are appointed by the Director, NMSS as Special Government Employees. The Committee consists of 13 members, including health care professionals in diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration, and patient care advocacy, and an Agreement State representative.
- 13. Subcommittees:
The Committee does not have standing subcommittees. The full Committee may create ad hoc subcommittees that report to the full Committee.
- 14. Recordkeeping:
The Committee records will be handled in accordance with General Records Schedule 6.2 and approved NRC records disposition schedules. These records shall be available for public inspection and copying, subject to the Freedom of Information Act, 5 U.S.C. 552.
- 15. Filing date:
February 28, 2024 Russell E. Chazell Federal Advisory Committee Management Officer Office of the Secretary